Significant therapeutic response was observed in a clinical case of a 46-year-old patient (ZSHS-048) diagnosed with metastatic ccRCC harboring dual-loss of PBRM1 and RAD51 (Fig. 3F). Here, RAD51 is linked to nonpapillary renal cell carcinoma.